fashion -WSS

fashion

author：explore 2025-10-01 18:35:30 - browse：65

A person reaching for a bottle of lipitor. -- first opinion coverage from STAT — John Moore/Getty Images

The antibiotics crisis is a silent pandemic that threatens to knock modern society back into the medieval age of therapeutic leaches and serum therapy. A world where an accidental scratch in the rose garden can kill.

Why is the supply of new antibiotics so thin, and growing thinner? A high-profile Wall Street Journal article recently highlighted what everyone knows: There is huge need but no market demand.

There are many interrelated causes. Doctors prefer to keep novel antibiotics in reserve, as a last-resort option, limiting sales volumes. Insurance companies like novel antibiotics that prevent costly ICU stays, but they’re used to the cheap price of older generics and balk at any price that allows recoupment of the full cost of development. Low prices and small volumes are a great recipe for insolvency as Achaogen’s experience showed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Spinal cord stimulation reduces pain in amputees, study finds

entertainment

WSS

Trump's false claims about Georgia's 2020 election long debunked

ActiGraph execs on goal of drug approvals with digital endpoints

Trump's false claims about Georgia's 2020 election long debunked

Patients' immediate access to test results puts radiologists in a bind

Why sickle cell disease is getting the first CRISPR treatment

Cancer drug shortages' outsize impact on ovarian cancer patients

leisure time

fashion

explore

Medicare details structure of new drug price negotiation program

FDA approves first treatment for ultra

BioMarin wins approval for gene therapy to treat hemophilia A

Patients' immediate access to test results puts radiologists in a bind

Alkermes shareholders re

Pfizer plans to depart BIO

Heart attack and stroke risk calculators need revising

Living with Hashimoto's and celiac disease, and med school, too

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Evacuations in place as 3 wildfires burn in eastern Washington state

focus

After sickle

Chemotherapy shortages won’t get better under Biden’s latest plan

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

After sickle

Americans' trust in science, scientist continues decline: Report

Cancer drug shortages' outsize impact on ovarian cancer patients

focus

entertainment

knowledge

hotspot